409 related articles for article (PubMed ID: 11192296)
1. Altered prevalence and reactivity of anti-Epstein-Barr virus antibodies in patients with multiple sclerosis.
Wagner HJ; Hennig H; Jabs WJ; Siekhaus A; Wessel K; Wandinger KP
Viral Immunol; 2000; 13(4):497-502. PubMed ID: 11192296
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples.
Salzer J; Nyström M; Hallmans G; Stenlund H; Wadell G; Sundström P
Mult Scler; 2013 Oct; 19(12):1587-91. PubMed ID: 23549431
[TBL] [Abstract][Full Text] [Related]
3. Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis.
Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
JAMA; 2005 May; 293(20):2496-500. PubMed ID: 15914750
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study.
Ascherio A; Munger KL; Lennette ET; Spiegelman D; Hernán MA; Olek MJ; Hankinson SE; Hunter DJ
JAMA; 2001 Dec; 286(24):3083-8. PubMed ID: 11754673
[TBL] [Abstract][Full Text] [Related]
5. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
Farrell RA; Antony D; Wall GR; Clark DA; Fisniku L; Swanton J; Khaleeli Z; Schmierer K; Miller DH; Giovannoni G
Neurology; 2009 Jul; 73(1):32-8. PubMed ID: 19458321
[TBL] [Abstract][Full Text] [Related]
6. Multiple sclerosis and Epstein-Barr virus.
Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
JAMA; 2003 Mar; 289(12):1533-6. PubMed ID: 12672770
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Epstein-Barr virus-specific antibodies in Cypriot multiple sclerosis patients.
Deeba E; Koptides D; Gaglia E; Constantinou A; Lambrianides A; Pantzaris M; Krashias G; Christodoulou C
Mol Immunol; 2019 Jan; 105():270-275. PubMed ID: 30562647
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.
Chen CJ; Lin KH; Lin SC; Tsai WC; Yen JH; Chang SJ; Lu SN; Liu HW
J Rheumatol; 2005 Jan; 32(1):44-7. PubMed ID: 15630723
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus and disease activity in multiple sclerosis.
Buljevac D; van Doornum GJ; Flach HZ; Groen J; Osterhaus AD; Hop W; van Doorn PA; van der Meché FG; Hintzen RQ
J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1377-81. PubMed ID: 16170080
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up.
DeLorenze GN; Munger KL; Lennette ET; Orentreich N; Vogelman JH; Ascherio A
Arch Neurol; 2006 Jun; 63(6):839-44. PubMed ID: 16606758
[TBL] [Abstract][Full Text] [Related]
11. [Investigation of Epstein-Barr virus and herpes simplex virus markers by serological and molecular methods in patients with rheumatoid arthritis and systemic lupus erythematosus].
Us T; Cetin E; Kaşifoğlu N; Kaşifoğlu T; Akgün Y
Mikrobiyol Bul; 2011 Oct; 45(4):677-83. PubMed ID: 22090298
[TBL] [Abstract][Full Text] [Related]
12. Gender influence in EBV antibody response in multiple sclerosis patients from Kuwait.
Al-Temaimi R; Alroughani R; Jacob S; Al-Mulla F
J Neuroimmunol; 2015 Aug; 285():57-61. PubMed ID: 26198919
[TBL] [Abstract][Full Text] [Related]
13. High seroprevalence of Epstein-Barr virus in children with multiple sclerosis.
Pohl D; Krone B; Rostasy K; Kahler E; Brunner E; Lehnert M; Wagner HJ; Gärtner J; Hanefeld F
Neurology; 2006 Dec; 67(11):2063-5. PubMed ID: 17159123
[TBL] [Abstract][Full Text] [Related]
14. Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk.
Strautins K; Tschochner M; James I; Choo L; Dunn DS; Pedrini M; Kermode A; Carroll W; Nolan D
Mult Scler; 2014 Mar; 20(3):286-94. PubMed ID: 23886832
[TBL] [Abstract][Full Text] [Related]
15. Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis.
Abrahamyan S; Eberspächer B; Hoshi MM; Aly L; Luessi F; Groppa S; Klotz L; Meuth SG; Schroeder C; Grüter T; Tackenberg B; Paul F; Then-Bergh F; Kümpfel T; Weber F; Stangel M; Bayas A; Wildemann B; Heesen C; Zettl U; Warnke C; Antony G; Hessler N; Wiendl H; Bittner S; Hemmer B; Gold R; Salmen A; Ruprecht K; ;
J Neurol Neurosurg Psychiatry; 2020 Jul; 91(7):681-686. PubMed ID: 32371533
[TBL] [Abstract][Full Text] [Related]
16. No evidence for intrathecal IgG synthesis to Epstein Barr virus nuclear antigen-1 in multiple sclerosis.
Jafari N; van Nierop GP; Verjans GM; Osterhaus AD; Middeldorp JM; Hintzen RQ
J Clin Virol; 2010 Sep; 49(1):26-31. PubMed ID: 20638898
[TBL] [Abstract][Full Text] [Related]
17. Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.
Loebel M; Eckey M; Sotzny F; Hahn E; Bauer S; Grabowski P; Zerweck J; Holenya P; Hanitsch LG; Wittke K; Borchmann P; Rüffer JU; Hiepe F; Ruprecht K; Behrends U; Meindl C; Volk HD; Reimer U; Scheibenbogen C
PLoS One; 2017; 12(6):e0179124. PubMed ID: 28604802
[TBL] [Abstract][Full Text] [Related]
18. Serological Evidence for the Association Between Epstein-Barr Virus Infection and Sjögren's Syndrome.
Xuan J; Ji Z; Wang B; Zeng X; Chen R; He Y; Rao P; Wu P; Shi G
Front Immunol; 2020; 11():590444. PubMed ID: 33193425
[TBL] [Abstract][Full Text] [Related]
19. Fine specificity of the antibody response to Epstein-Barr nuclear antigen-2 and other Epstein-Barr virus proteins in patients with clinically isolated syndrome: A peptide microarray-based case-control study.
Schlemm L; Giess RM; Rasche L; Pfuhl C; Wakonig K; Behrens JR; Scheibenbogen C; Bellmann-Strobl J; Paul F; Reimer U; Ruprecht K
J Neuroimmunol; 2016 Aug; 297():56-62. PubMed ID: 27397076
[TBL] [Abstract][Full Text] [Related]
20. Increased Epstein-Barr Virus DNA Load and Antibodies Against EBNA1 and EA in Sardinian Patients with Rheumatoid Arthritis.
Erre GL; Mameli G; Cossu D; Muzzeddu B; Piras C; Paccagnini D; Passiu G; Sechi LA
Viral Immunol; 2015 Sep; 28(7):385-90. PubMed ID: 26083265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
